Literature DB >> 3218072

Use of recombinant vaccinia-rabies virus for oral vaccination of fox cubs (Vulpes vulpes, L) against rabies.

B M Brochier1, B Languet, J Blancou, M P Kieny, J P Lecocq, F Costy, P Desmettre, P P Pastoret.   

Abstract

Thirteen fox cubs were orally administered 10(7.2) plaque-forming units of live vaccinia-rabies glycoprotein recombinant virus. On Day 28 post-vaccination, all but 1 cub had produced rabies virus antibodies. Twelve animals were intramuscularly inoculated with 10(3.2) mouse intracerebral LD50 of rabies virus suspension on Days 33 (5 foxes), 180 (4 foxes) or 360 (3 foxes) after vaccination. Eleven of them resisted rabies challenge. Unvaccinated foxes, either put in contact with 1 vaccinated animal or used as controls, died after challenge applied on Day 33. The absence of horizontal transmission of this vaccine strain and its innocuity to cubs were also demonstrated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3218072     DOI: 10.1016/0378-1135(88)90055-7

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  12 in total

Review 1.  Rabies in Britain.

Authors:  D A Tyrrell; K G Nicholson
Journal:  BMJ       Date:  1990-01-20

2.  Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection.

Authors:  D L Lodmell; J W Sumner; J J Esposito; W J Bellini; L C Ewalt
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.

Authors:  Mark R Scheckelhoff; Sam R Telford; Linden T Hu
Journal:  Vaccine       Date:  2005-11-04       Impact factor: 3.641

4.  Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in Canadian wildlife.

Authors:  M Artois; K M Charlton; N D Tolson; G A Casey; M K Knowles; J B Campbell
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

5.  The live vector approach-viruses.

Authors:  M Mackett
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

6.  Genetic recombination of pseudorabies virus: evidence that homologous recombination between insert sequences is less frequent than between autologous sequences.

Authors:  K L Glazenburg; R J Moormann; T G Kimman; A L Gielkens; B P Peeters
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  The elimination of fox rabies from Europe: determinants of success and lessons for the future.

Authors:  Conrad M Freuling; Katie Hampson; Thomas Selhorst; Ronald Schröder; Francois X Meslin; Thomas C Mettenleiter; Thomas Müller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 8.  Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review.

Authors:  Joanne Maki; Anne-Laure Guiot; Michel Aubert; Bernard Brochier; Florence Cliquet; Cathleen A Hanlon; Roni King; Ernest H Oertli; Charles E Rupprecht; Caroline Schumacher; Dennis Slate; Boris Yakobson; Anne Wohlers; Emily W Lankau
Journal:  Vet Res       Date:  2017-09-22       Impact factor: 3.683

Review 9.  Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?

Authors:  Malachy I Okeke; Arinze S Okoli; Diana Diaz; Collins Offor; Taiwo G Oludotun; Morten Tryland; Thomas Bøhn; Ugo Moens
Journal:  Viruses       Date:  2017-10-29       Impact factor: 5.048

10.  Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife.

Authors:  Susan M Moore; Amy Gilbert; Ad Vos; Conrad M Freuling; Christine Ellis; Jeannette Kliemt; Thomas Müller
Journal:  Trop Med Infect Dis       Date:  2017-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.